AIA
MRNA icon

Arbor Investment Advisors’s Moderna MRNA Stock Holding History

Arbor Investment Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-5,000
Closed -$516K – 105
2023
Q3 		$516K Hold
5,000
– – 0.09% 53
2023
Q2 		$608K Hold
5,000
– – 0.11% 51
2023
Q1 		$768K Hold
5,000
– – 0.14% 44
2022
Q4 		$898K Buy
+5,000
New +$818K 0.18% 40

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arbor Investment Advisors's MRNA Position: Q4 2023 in Review

Arbor Investment Advisors sold out of Moderna (MRNA) in Q4 2023, closing a stake of 5,000 shares — an estimated $516K sold.

Arbor Investment Advisors first reported a position in MRNA in Q4 2022 and held it in 4 quarters. The position peaked at $898K in Q4 2022. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Arbor Investment Advisors reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
  • Arbor Investment Advisors sold 5,000 Moderna shares in Q4 2023, an estimated $516K.
  • Arbor Investment Advisors first reported a position in Moderna in Q4 2022 and held it in 4 quarters.
  • Arbor Investment Advisors's Moderna position peaked at $898K in Q4 2022.
  • 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Arbor Investment Advisors's 13F filing for Q4 2023, filed 29 Jan 2024.